Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Arthur Desrosiers

Plastic and Reconstructive Surgery Miami, FL Medical Doctor

NPI 1770700429 CMS profile 1267268

3100 Sw 62Nd Ave, Suite 2230, Miami, FL 33155

Open in the dashboard

General payments

$155,726

492 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Arthur Desrosiers of Miami, FL is reported in the CMS Open Payments database as having received $155,726 across 492 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,226 41
2024 General $11,339 44
2023 General $29,068 99
2022 General $24,874 105
2021 General $21,833 60
2020 General $14,877 48
2019 General $35,509 95

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Arthur Desrosiers
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Arthur Desrosiers were reported at $18,226. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Arthur Desrosiers Plastic and Reconstructive Surgery median Middle half National median
2019 $35,509 $335 $121–$1,264 $163
2020 $14,877 $162 $57–$417 $114
2021 $21,833 $245 $89–$735 $132
2022 $24,874 $325 $120–$932 $149
2023 $29,068 $343 $129–$999 $160
2024 $11,339 $390 $141–$1,085 $164
2025 $18,226 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organogenesis Inc. $122,722 278 payments
  2. Sanara MedTech Inc. $12,433 30 payments
  3. Aroa Biosurgery Incorporated $6,677 32 payments
  4. Stryker Corporation $2,272 16 payments
  5. Integra LifeSciences Corporation $2,040 27 payments
  6. KCI USA, Inc $1,651 11 payments
  7. PolyNovo North America LLC $1,466 22 payments
  8. TELA Bio, Inc. $1,449 24 payments
  9. Smith+Nephew, Inc. $938 11 payments
  10. Musculoskeletal Transplant Foundation Inc. $592 4 payments
  11. Other $3,486 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $98,871 92 payments
  2. Food and Beverage $21,721 279 payments
  3. Consulting Fee $15,364 11 payments
  4. Travel and Lodging $13,524 105 payments
  5. Honoraria $5,800 3 payments
  6. Education $447 2 payments
Products named General payments · program years 2019–2025
  1. Apligraf Podiatry $32,794 71 payments
  2. Puraply/Affinity/NuTech $32,794 71 payments
  3. Dermagraft $32,794 71 payments
  4. Puraply Antimicrobial $31,545 73 payments
  5. Puraply $29,089 84 payments
  6. PURAPLY WOUND MATRIX $25,592 36 payments
  7. CellerateRx $12,554 31 payments
  8. Affinity $4,893 6 payments
  9. NuShield $1,906 2 payments
  10. APLIGRAF Wound Care $1,906 2 payments
  11. Other $25,686 292 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

492 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record